thyroid cancer

Vivian Weiss, MD, PhD, center, George Xu, left, and Matthew Loberg led a multidisciplinary study that identified a molecular signature for aggressive thyroid cancer, which could help guide treatment approaches for patients. (photo by Susan Urmy)

September 25, 2023

Researchers discover molecular signature for aggressive thyroid cancer

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

By Leigh MacMillan

January 19, 2023

Pediatric surgeon’s medical career began with a lucky catch

While he was in medical school, pediatric surgeon Joseph Fusco, MD, learned in an unusual way that he had thyroid cancer.

By Jessica Pasley

Yike Li, PhD, and Maria Powell, PhD, examine patient Judit Kiss during a follow-up appointment at the Vanderbilt Voice Center.

October 20, 2022

Implanted stimulator used to treat vocal cord paralysis

Vanderbilt is the only place in the world that has an implantable bilateral pacemaker that can stimulate opening of both vocal folds in patients with bilateral vocal fold paralysis, allowing them to both breathe and speak.

By Craig Boerner

December 2, 2021

Thyroid cancer paper lands national recognition

By Doug Campbell

August 26, 2021

Obese children, young adults at higher risk for thyroid cancer

Children and young adults who are obese are at greater risk for malignant thyroid nodules, according to new study from Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Christina Echegaray

Carmen Solórzano, MD, left, Emmanuel Mannoh, Giju Thomas, PhD, Naira Baregamian, MD, and colleagues are testing a device to assist in locating parathyroid glands during surgery.

February 13, 2020

Clinical trial tests device that detects parathyroid glands

Vanderbilt is testing a device to assist in locating parathyroid glands during surgery.

By Jill Clendening

November 7, 2019

Grant bolsters Weiss’ pediatric thyroid cancer research

Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.

By Tom Wilemon

November 15, 2018

Surgeon helps restore cancer patients’ functionality

Sarah Rohde long had an interest in treating cancer, and her research during her undergraduate and medical school years at the University of Virginia underscored that. What she didn’t expect was to become a surgeon.